DRIO DarioHealth Corp. Common Stock
XNAS
8.00
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $3.01 – $16.44
- YTD
- -23.95%
- Straddle Price
- $7.45
- P/C Vol Ratio
- 0.00
- Market Cap
- $0.0B
- Open
- $3.62
- Day Range
- $3.25 – $4.04
- Volume
- 99,291
- Prev Close
- $3.77
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 1.07 |
| Cost of Equity (CAPM) | 10.05% (VRP-adj) |
| WACC | 5.23% |
| Volatility Risk Premium | -88.6pp (IV − HV30), ERP adj -25bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +3.4% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | 14913.5% |
| Gross Margin (TTM) | 58.2% |
| FCF Margin (TTM) | -121.3% |
| Debt / Equity | 0.56 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $6.29 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $5.21 |
| Bollinger Width / SMA20 | 1535.3% (drives anchor stability) |
| Net Debt | $0.0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 31.6× · 5 peers |
| Peer EV/EBITDA | n/a | 0% | median 18.6× · 6 peers |
| Peer P/B | n/a | 0% | median 2.7× · 6 peers |
| Peer P/S | n/a | 0% | median 2.2× · 6 peers |
| Market Anchor (SMA50) | $6.29 | 100% | stability 76% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 165
- List Date
- 2013-03-08
- CIK
- 0001533998
- Next Earnings
- 2026-11-12
- EPS Forecast
- ($0.68) (1 est.)
- Headquarters
- New York, NY
- Homepage
- https://www.mydario.com
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 40.56% | -35.56% | 27.36% | 11.83% | -24.48% | -4.75% | 2.49% |
| Feb | 8.66% | -16.76% | -15.29% | 6.28% | 10.46% | 9.41% | 0.46% |
| Mar | -29.11% | -23.76% | -10.24% | -23.31% | -4.61% | -25.40% | -19.40% |
| Apr | 6.38% | -17.74% | -14.25% | -4.05% | 21.16% | -11.79% | -3.38% |
| May | -25.23% | 30.65% | 20.74% | -2.05% | -1.04% | 6.16% | 4.87% |
| Jun | 28.06% | -2.23% | 0.25% | -19.05% | -4.30% | -14.29% | -1.93% |
| Jul | -28.89% | 3.04% | -10.12% | -7.69% | -19.30% | 6.60% | -9.39% |
| Aug | -8.67% | -17.62% | -14.95% | -22.12% | -13.53% | 3.80% | -12.18% |
| Sep | 2.02% | 1.09% | 2.50% | 34.96% | 89.62% | -5.70% | 20.75% |
| Oct | 22.01% | -6.34% | -62.24% | -3.99% | -18.59% | -44.81%* | -18.99% |
| Nov | -13.65% | 11.46% | 19.80% | -16.73% | -13.10% | -- | -2.44% |
| Dec | -12.78% | -11.57% | 21.99% | 1.96% | -3.56% | -- | -0.79% |
| Total | -32.85% | -65.96% | -56.54% | -45.16% | -17.57% | -64.07% | -47.02% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
SYMBOL: DRIO
Executive Summary: Overall assessment: NEUTRAL (Confidence level: 6/10)
Key drivers:
- Technical indicators suggest a range-bound market with potential for mean reversion.
- News sentiment is neutral, with no significant catalysts driving the stock's recent movement.
Primary risks:
- Low volatility may indicate limited upside potential.
- Options market pricing suggests a relatively low expected move by expiration, which could limit price movements.
Investment thesis: DRIO appears to be in a consolidation phase, with technical indicators suggesting a range-bound market. The neutral news sentiment and low volatility suggest limited risk of significant price movements. A patient approach with a focus on mean reversion or breakout signals may yield better returns than an impulsive trading strategy.
Recent news sentiment impact: Neutral
Technical Analysis:
- Trend Direction: Range-bound (1-4 weeks), Medium-term (1-3 months)
- Support/Resistance Levels: $7.12 (SMA 20), $7.18 (SMA 50), $6.61 (Bollinger Bands Lower)
- Momentum Signals:
- RSI interpretation: Neutral (47.31%)
- MACD signal: Bearish
- Bollinger Bands position: Neutral
- Volume Analysis: Volume SMA 20: 27411.10, On-Balance Volume (OBV): 1480072.28, Volume Rate of Change: 131.26%
News & Sentiment Analysis:
- Recent Headlines Summary: Neutral news headlines with no significant catalysts driving the stock's recent movement.
- Sentiment Assessment: Neutral
- Catalyst Identification: No immediate or near-term catalysts identified.
- Market Narrative: The market narrative is neutral, with no strong trends or sentiment shifts driving the stock's price.
Risk & Volatility Assessment:
- Beta Interpretation: Low risk relative to market (beta = 0.22)
- Volatility Regime: Low volatility - stock moves less than market
- Options Market Signals: IV Rank: 0.0% (Low), Current IV: 0.0%, Expected Move: $7.45, Volume Flow: 1 calls vs 0 puts, Open Interest: 111 calls vs 0 puts, Put/Call Volume Ratio: 0.00 (Bullish sentiment)
- Downside Protection: Support levels at $6.61 and $7.12 may provide some downside protection.
Market Context & Positioning:
- Sector Performance: Neutral
- Institutional Activity: No unusual institutional activity observed.
- Correlation Analysis: Low correlation with the market (R-squared interpretation)
- Relative Valuation: Position within a trading range, with no clear relative valuation signals.
Key Levels & Action Items:
- Critical Price Levels: $7.12 (SMA 20), $7.18 (SMA 50), $6.61 (Bollinger Bands Lower)
- Breakout/Breakdown Levels: No immediate or near-term levels identified.
- Time-Sensitive Catalysts: No earnings dates or significant events scheduled for the next quarter.
- Risk Management: Consider a stop-loss level at $7.12 to limit potential losses, and consider scaling into positions as the stock approaches key levels.
This comprehensive analysis provides an objective assessment of DRIO's technical indicators, news sentiment, risk metrics, and market context. The report highlights the stock's neutral market narrative, low volatility, and limited price movements, suggesting a patient approach with a focus on mean reversion or breakout signals may yield better returns than an impulsive trading strategy.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-08-16 | After-Close | 3.08% | 0.86% | 0.28x | Within |
| 2022-01-19 | After-Close | 1.66% | 7.67% | 4.62x | Exceeded |
| 2022-08-15 | After-Close | 2.41% | 13.06% | 5.42x | Exceeded |
| 2023-07-24 | unknown | 128.98% | 6.23% | 0.05x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
DRIO Options Activity & IV Rank
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 250
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $160K | #5584 of 6285 | +18.7% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
DRIO Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
DRIO Insider Trading (Form 4)
Latest: 2026-09-28| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | John R Palumbo | Director | Award (A) | +62,000 | — | EDGAR | |
| 2026-09-28 | Dennis M McGrath | Director | Award (A) | +61,000 | — | EDGAR | |
| 2026-09-28 | Dennis Matheis | Director | Award (A) | +44,000 | — | EDGAR | |
| 2026-09-28 | Hila Karah | Director | Award (A) | +28,000 | — | EDGAR | |
| 2026-09-28 | Chen Franco-Yehuda | Chief Financial Officer | Award (A) | +95,000 | — | EDGAR | |
| 2026-09-28 | Yoav Shaked | Director | Mixed | +54,772 | $19.10 | $14.7K | EDGAR |
| 2026-09-28 | Adam K Stern | Director | Mixed | +48,195 | $30.46 | $615.1K | EDGAR |
| 2026-09-28 | Erez Raphael | Chief Executive Officer | Mixed | +297,579 | $19.10 | $11.1K | EDGAR |
| 2026-07-28 | Dennis Matheis | Director | Mixed | +15,395 | $7.69 | $118.4K | EDGAR |
| 2025-09-15 | Dennis M McGrath | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-09-15 | Hila Karah | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-09-15 | Dennis Matheis | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-09-15 | Yoav Shaked | Director | Award (A) | +20,000 | — | EDGAR | |
| 2025-09-15 | Steven Charles Nelson | President and CCO | Award (A) | +30,000 | — | EDGAR | |
| 2025-09-15 | Chen Franco-Yehuda | Chief Financial Officer | Award (A) | +5,000 | — | EDGAR |
DRIO Insider Holdings
11 insiders · @ $3.40| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Erez Raphael | Chief Executive Officer | 159,326 | $541.7K | -$1.99M | 17 | 2026-09-28 |
| 2 | Chen Franco-Yehuda | Chief Financial Officer | 125,000 | $425.0K | $0 | 3 | 2026-09-28 |
| 3 | Dennis M McGrath | Director | 88,737 | $301.7K | -$1.19M | 7 | 2026-09-28 |
| 4 | Dennis Matheis | Director | 87,026 | $295.9K | $100.0K | 7 | 2026-09-28 |
| 5 | Adam K Stern | Director | 75,623 | $257.1K | $0 | 7 | 2026-09-28 |
| 6 | John R Palumbo | Director | 66,500 | $226.1K | $0 | 1 | 2026-09-28 |
| 7 | Hila Karah | Director | 58,965 | $200.5K | $0 | 4 | 2026-09-28 |
| 8 | Steven Charles Nelson | President and CCO | 34,750 | $118.2K | $69.7K | 8 | 2025-09-15 |
| 9 | Yoav Shaked | Director | 33,666 | $114.5K | $0 | 5 | 2026-09-28 |
| 10 | Lawrence B. Leisure | Director | 32,900 | $111.9K | $0 | 1 | 2025-09-15 |
DRIO Board & Officers
As of SEC filings through Sep 28, 2026Directors 8
- Adam K Stern · since Feb 15, 2013
- Dennis M McGrath · since Mar 3, 2016
- Erez Raphael · since Mar 3, 2016
- Hila Karah · since Mar 3, 2016
- Yoav Shaked · since Jul 5, 2018
- Dennis Matheis · since Jul 2, 2020
- Lawrence B. Leisure · since Feb 25, 2025
- John R Palumbo · since Apr 10, 2026
Officers 4
- Erez Raphael · Chief Executive Officer · since Mar 3, 2016
- Steven Charles Nelson · President and CCO · listed since Aug 2025
- Chen Franco-Yehuda · Chief Financial Officer · since May 15, 2025
- Lara Ann Sherman · Chief Operating Officer · since Sep 24, 2026
Changes in the last 10 years (39)
| Sep 24, 2026 | Lara Ann Sherman became Chief Operating Officer |
| Apr 10, 2026 | John R Palumbo became a director |
| Aug 27, 2025 | Steven Charles Nelson listed as President and CCO (previously Chief Commercial Officer) in SEC filings |
| May 15, 2025 | Chen Franco-Yehuda became Chief Financial Officer |
| Apr 18, 2025 | The company announced the departure of Zvi Ben-David as Chief Financial Officer in an SEC filing |
| Feb 25, 2025 | Lawrence B. Leisure became a director |
| Feb 24, 2025 | The company announced the departure of Jon H. Kaplan from the board in an SEC filing |
| Jun 5, 2024 | Steven Charles Nelson became Chief Commercial Officer |
| May 30, 2024 | The company announced the departure of Richard Alan Anderson as President, GM of North America in an SEC filing |
| Feb 15, 2024 | Tomer Ben-Kiki became Chief Operating Officer |
| Feb 22, 2023 | Jon H. Kaplan became a director |
| Jan 23, 2023 | The company announced the departure of Dror Bacher as Chief Operating Officer in an SEC filing |
| Oct 12, 2021 | Erez Raphael no longer listed as a 10% owner in SEC filings |
| Feb 1, 2021 | Oded Cohen became Gm Msk |
| Jan 21, 2021 | Erez Raphael first listed as a 10% owner in an SEC filing |
| Jul 2, 2020 | Dennis Matheis became a director |
| Apr 7, 2020 | Yalon Farhi reported in an SEC filing no longer being a director |
| Apr 7, 2020 | Erez Raphael no longer listed as a 10% owner in SEC filings |
| Mar 25, 2020 | Erez Raphael first listed as a 10% owner in an SEC filing |
| Mar 1, 2020 | Yadin Shemmer became a director |
| Jan 30, 2020 | Olivier Roger Jarry reported in an SEC filing no longer being President and Chief Commercial Officer |
| Jan 30, 2020 | Glen Moller reported in an SEC filing no longer being a director |
| Jan 7, 2020 | Richard Alan Anderson became President, GM of North America |
| Apr 30, 2019 | Erez Raphael no longer listed as a 10% owner in SEC filings |
| Oct 16, 2018 | Glen Moller became a director |
| Aug 30, 2018 | Olivier Roger Jarry became President and Chief Commercial Officer |
| Jul 5, 2018 | Yoav Shaked became a director |
| Apr 25, 2018 | Yossi Bahagon reported in an SEC filing no longer being a director |
| Apr 25, 2018 | Yossi Bahagon reported in an SEC filing no longer being a 10% owner |
| Apr 25, 2018 | Allen Kamer no longer listed as a 10% owner in SEC filings |
| Apr 1, 2018 | Ori Zanco became a director |
| Dec 4, 2017 | Shehnee Farhi became a 10% owner |
| Jul 25, 2017 | Dror Bacher became Chief Operating Officer |
| Jul 11, 2017 | Erez Raphael first listed as a 10% owner in an SEC filing |
| Feb 28, 2017 | Yossi Bahagon became a director |
| Feb 28, 2017 | Yossi Bahagon became a 10% owner |
| Feb 28, 2017 | Allen Kamer became a director |
| Feb 28, 2017 | Allen Kamer became a 10% owner |
| Jan 9, 2017 | OurCrowd Digital Health L.P. became a 10% owner |
- Prev
- 1
Not reported recently (10)
- Tomer Ben-Kiki · Last reported as Chief Operating Officer in an SEC filing dated Feb 21, 2024
- Richard B Stone · Last reported as a director in an SEC filing dated May 20, 2022
- Oded Cohen · Last reported as Gm Msk in an SEC filing dated Oct 15, 2021
- Allen Kamer · Last reported as a director in an SEC filing dated Oct 13, 2020
- Yadin Shemmer · Last reported as a director in an SEC filing dated Mar 5, 2020
- Hod Rami Yehudiha · Last reported as a director in an SEC filing dated Oct 5, 2018
- Ori Zanco · Last reported as a director in an SEC filing dated Oct 5, 2018
- Malcolm Hoenlein · Last reported as a director in an SEC filing dated Jun 8, 2018
- Shehnee Farhi · Last reported as a 10% owner in an SEC filing dated Feb 14, 2018
- OurCrowd Digital Health L.P. · Last reported as a 10% owner in an SEC filing dated Jan 27, 2017
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $512,017 | — | 2026-09-30 |
| 2 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.01% | $69,202 | $1.2B | 2026-10-23 |
| 3 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $4,524 | — | 2026-10-23 |
| 4 | DFSU Dimensional US Sustainability Core 1 ETF | Dimensional | 0.00% | $2,816 | $2.4B | 2026-10-23 |
| 5 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $754 | — | 2026-10-23 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $5.18M | $-7.92M | $-0.85 | $-6.08M |
| Q1 '26 | 2026-03-31 | $5.58M | $8.25B | $1.25 | $-6.03M |
| Q4 '25 | 2025-12-31 | $5.23M | $-16.11M | $-1.07 | $-5.89M |
| Q3 '25 | 2025-09-30 | $5.01M | $-9.28M | $-2.96 | $-7.35M |
| Q2 '25 | 2025-06-30 | $5.37M | $-8.78M | $-3.54 | $-6.03M |
| Q1 '25 | 2025-03-31 | $6.75M | $6.79B | $2.87 | $-6.67M |
| Q4 '24 | 2024-12-31 | $7.60M | $-9.79M | $-1.89 | $-6.73M |
| Q3 '24 | 2024-09-30 | $7.42M | $-9.92M | $-4.91 | $-7.36M |
| Q2 '24 | 2024-06-30 | $6.25M | $-3.37M | $-1.60 | $-11.36M |
| Q1 '24 | 2024-03-31 | $5.76M | $-6.92B | $-4.00 | $-13.11M |
| Q4 '23 | 2023-12-31 | $3.62M | $-12.00M | $-8.20 | $-7.34M |
| Q3 '23 | 2023-09-30 | $3.52M | $-14.20M | $-9.80 | $-8.64M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.